Trends in the pricing and reimbursement of new anticancer drugs in South Korea: an analysis of listed anticancer drugs during the past three years

Kim, Sungju; Kim, Jin-Hong; Cho, Hyunyoung; Lee, Kyungmin; Ryu, Chiyoung; Hyuk Lee, Jong

doi:10.1080/14737167.2021.1860023

Public

Trends in the pricing and reimbursement of new anticancer drugs in South Korea: an analysis of listed anticancer drugs during the past three years

Published in Expert Review of Pharmacoeconomics & Outcomes Research • Dec 4, 2020

Authors:

Sungju Kim

Jin-Hong Kim

Hyunyoung Cho

Abstract

Objective: This study aimed to examine patient accessibility to new anticancer drugs including reimbursement coverage, time to listing, and listing price during the recent 3 years after the introduction of alternative pricing and reimbursement pathways in South Korea.Methods: Anticancer drugs were s...

Subject

Reimbursement

Listing (finance)

Descriptive statistics

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!